Latest Breaking News On - Belgian transparency - Page 9 : vimarsana.com

Regulated Information Leuven, BELGIUM, Boston, MA, US – September 18, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a first transparency notification on September 14, 2023, from Atlas Special Oppor

Region flamandeUnited statesMaryt conwayMichael dillenTom graneyCompany annualAtlas special opportunitiesConway communicationsEuronext brusselsBelgian transparencyIopharmaceutical companyRetinal disordersAtlas special opportunities